Glioblastoma Patient Virtual Advisory Board
Seeking GBM Patients and/or Caregivers
THE BOARD IS FULL. THIS OPPORTUNITY IS CLOSED.
The Center for Information & Study on
Clinical Research Participation
CISCRP is planning a virtual patient advisory board among individuals diagnosed with Glioblastoma and their caregivers.
(THE BOARD IS FULL. THIS OPPORTUNITY IS CLOSED.)
What is the purpose of this patient advisory board project?
This patient advisory board will provide an opportunity for those diagnosed with Glioblastoma and their loved ones to share their experiences living with this condition. This feedback will help the pharmaceutical company improve experiences for future study volunteers enrolled in clinical trials.
Who can participate?
CISCRP is looking for adult patients diagnosed with Glioblastoma with an IDH1 or IDH2 biomarker, and/or their caregivers. Participants should be proficient in English, and willing to share their experiences.
When would the patient advisory boards take place and what would it be like to participate?
The virtual patient advisory board would take place in March 2025. The meetings will be conducted virtually using an online platform (Zoom) as two, 2-hour meetings.
Will the participants be compensated?
As a thank you for your time, CISCRP will provide compensation to those who are eligible and participate. Participants will receive an honorarium of $90 USD per hour ($360 for 4 hours) for taking part in the project.
The Center for Information and Study on Clinical Research Participation (CISCRP) is an independent non-profit organization, dedicated to including the voice of the community in the clinical research process. As part of our mission, we regularly engage with affected individuals and families through patient (or community) advisory board meetings, global surveys, and workshops to include the community voice in research endeavors.
